/ELMD
ELMD Stock - Electromed, Inc.
Healthcare|Medical - DevicesAMEX
$27.90-2.75%
$0.79 (-2.75%) • Jan 13
86
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.82
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+27.2%upside
Target: $35.49
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ELMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$27.62 – $28.18
TARGET (TP)$35.50
STOP LOSS$25.67
RISK/REWARD1:3.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.27
52W High$35.56
52W Low$17.73
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $64.00M | $54.72M | $48.07M | $41.66M | $35.76M |
| Gross Profit | $49.97M | $41.73M | $36.52M | $31.44M | $27.30M |
| Gross Margin | 78.1% | 76.3% | 76.0% | 75.5% | 76.4% |
| Operating Income | $9.66M | $6.58M | $4.01M | $2.97M | $3.14M |
| Net Income | $7.54M | $5.15M | $3.17M | $2.31M | $2.36M |
| Net Margin | 11.8% | 9.4% | 6.6% | 5.5% | 6.6% |
| EPS | $0.90 | $0.60 | $0.37 | $0.27 | $0.28 |
Company Overview
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
3 Bullish0 Neutral/Bearish
Price Targets
$34
Average Target
↑ 23.1% Upside
Now
$29
Low
$34
Average
$38
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 27th 2025 | Lake Street | Resumed | Buy | $36 |
| July 22nd 2025 | Roth Capital | Initiation | Buy | $29 |
| February 20th 2025 | B. Riley Securities | Initiation | Buy | $38 |
Earnings History & Surprises
ELMDBeat Rate
67%
Last 18 quarters
Avg Surprise
+39.4%
EPS vs Estimate
Beats / Misses
12/6
Last 12 quarters
Latest EPS
$0.25
Q4 2025
EPS Surprise History
Q1 24
+90.0%
$0.19vs$0.10
Q2 24
+30.8%
$0.17vs$0.13
Q3 24
+42.9%
$0.20vs$0.14
Q4 24
+433.3%
$0.16vs$0.03
Q1 25
+22.2%
$0.22vs$0.18
Q2 25
+5.0%
$0.21vs$0.20
Q3 25
+13.6%
$0.25vs$0.22
Q4 25
+13.6%
$0.25vs$0.22
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 10, 2026 | $0.27 | — | — | — |
Q4 2025 | Nov 12, 2025 | $0.22 | $0.25 | +13.6% | ✓ BEAT |
Q3 2025 | Aug 26, 2025 | $0.22 | $0.25 | +13.6% | ✓ BEAT |
Q2 2025 | May 13, 2025 | $0.20 | $0.21 | +5.0% | ✓ BEAT |
Q1 2025 | Feb 11, 2025 | $0.18 | $0.22 | +22.2% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $0.03 | $0.16 | +433.3% | ✓ BEAT |
Q3 2024 | Aug 27, 2024 | $0.14 | $0.20 | +42.9% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.13 | $0.17 | +30.8% | ✓ BEAT |
Q1 2024 | Feb 13, 2024 | $0.10 | $0.19 | +90.0% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.10 | $0.02 | -80.0% | ✗ MISS |
Q3 2023 | Aug 22, 2023 | $0.13 | $0.12 | -7.7% | ✗ MISS |
Q2 2023 | May 9, 2023 | $0.10 | $0.12 | +20.0% | ✓ BEAT |
Q1 2023 | Feb 14, 2023 | $0.04 | $0.11 | +214.3% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $0.04 | $0.01 | -71.4% | ✗ MISS |
Q3 2022 | Aug 23, 2022 | $0.08 | $0.04 | -50.0% | ✗ MISS |
Q2 2022 | May 10, 2022 | $0.05 | $0.07 | +40.0% | ✓ BEAT |
Q1 2022 | Feb 8, 2022 | $0.07 | $0.10 | +42.9% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | $0.06 | $0.05 | -16.7% | ✗ MISS |
Q3 2021 | Aug 24, 2021 | $0.06 | $0.04 | -33.3% | ✗ MISS |
Latest News
Roth Capital Reiterates Buy on Electromed, Raises Price Target to $36
📈 PositiveBenzinga•Nov 13, 2025, 05:14 PM
Electromed Q1 EPS $0.25 Beats $0.22 Estimate, Sales $16.887M Miss $17.000M Estimate
➖ NeutralBenzinga•Nov 12, 2025, 09:06 PM
Electromed, Inc. Announces $10M Share Repurchase Authorization
📈 PositiveBenzinga•Sep 9, 2025, 01:00 PM
Roth Capital Maintains Buy on Electromed, Raises Price Target to $35
📈 PositiveBenzinga•Aug 27, 2025, 06:09 PM
Lake Street Assumes Electromed at Buy, Announces Price Target of $36
📈 PositiveBenzinga•Aug 27, 2025, 06:01 PM
Electromed shares are trading higher after the company reported Q4 financial results and beat its EPS and revenue estimates.
📈 PositiveBenzinga•Aug 27, 2025, 12:30 PM
Electromed Posts 17% Gain in Fiscal Q4
📈 PositiveThe Motley Fool•Aug 26, 2025, 08:25 PM
Electromed shares are trading higher after the company reported Q4 financial results and beat its EPS and revenue estimates.
📈 PositiveBenzinga•Aug 26, 2025, 08:16 PM
Electromed Q4 EPS $0.25 Beats $0.22 Estimate, Sales $17.39M Beat $16.64M Estimate
📈 PositiveBenzinga•Aug 26, 2025, 08:14 PM
Frequently Asked Questions about ELMD
What is ELMD's current stock price?
Electromed, Inc. (ELMD) is currently trading at $27.90 per share. The stock has moved -2.75% today.
What is the analyst price target for ELMD?
The average analyst price target for ELMD is $35.50, based on 1 analyst.
What sector is Electromed, Inc. in?
Electromed, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the AMEX exchange.
What is ELMD's market cap?
Electromed, Inc. has a market capitalization of $0.23 billion, making it a small-cap company.
Does ELMD pay dividends?
No, Electromed, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCATX
Perspective Therapeutics, Inc.
$2.58
Mkt Cap: $0.2B
HSDT
Solana Company
$3.38
Mkt Cap: $0.1B
INFU
InfuSystem Holdings, Inc.
$8.35
Mkt Cap: $0.2B
INGN
Inogen, Inc.
$6.28
Mkt Cap: $0.2B
MXCT
MaxCyte, Inc.
$1.31
Mkt Cap: $0.1B
NNOX
Nano-X Imaging Ltd.
$2.98
Mkt Cap: $0.2B
OM
Outset Medical, Inc.
$5.26
Mkt Cap: $0.1B
PROF
Profound Medical Corp.
$8.44
Mkt Cap: $0.3B
TLSI
TriSalus Life Sciences, Inc.
$5.97
Mkt Cap: $0.2B
VMD
Viemed Healthcare, Inc.
$7.25
Mkt Cap: $0.3B
Explore stocks similar to ELMD for comparison